Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)
NiKang Therapeutics, Inc.
NiKang Therapeutics, Inc.
German Cancer Research Center
Atara Biotherapeutics
Becton, Dickinson and Company
Sesen Bio, Inc.
Cedars-Sinai Medical Center
Assistance Publique - HĂ´pitaux de Paris
Assistance Publique - HĂ´pitaux de Paris
Abbott